141 related articles for article (PubMed ID: 18990008)
21. Role of GSTM1 (Null/Present), GSTP1 (Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer: a case control study from South India.
Samson M; Swaminathan R; Rama R; Sridevi V; Nancy KN; Rajkumar T
Asian Pac J Cancer Prev; 2007; 8(2):253-7. PubMed ID: 17696741
[TBL] [Abstract][Full Text] [Related]
22. CYP1A1 Ile462Val polymorphism and the risk of non-small cell lung cancer in a Chinese population.
Lin J; He B; Cao L; Zhang Z; Liu H; Rao J; Liu Y; Shao S; Wang G; Zhang X
Tumori; 2014; 100(5):547-52. PubMed ID: 25343551
[TBL] [Abstract][Full Text] [Related]
23. Lack of association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk: a meta-analysis.
Wang XW; Zhong TY; Xiong YH; Lin HB; Liu QY
Asian Pac J Cancer Prev; 2012; 13(8):3717-21. PubMed ID: 23098461
[TBL] [Abstract][Full Text] [Related]
24. Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population.
Srivastava K; Srivastava A; Mittal B
J Hum Genet; 2010 Aug; 55(8):495-9. PubMed ID: 20520619
[TBL] [Abstract][Full Text] [Related]
25. Role of GSTM1 (Present/Null) and GSTP1 (Ile105Val) polymorphisms in susceptibility to acute lymphoblastic leukemia among the South Indian population.
Suneetha KJ; Nancy KN; Rajalekshmy KR; Sagar TG; Rajkumar T
Asian Pac J Cancer Prev; 2008; 9(4):733-6. PubMed ID: 19256768
[TBL] [Abstract][Full Text] [Related]
26. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
27. Relevance of glutathione S-transferase M1 and cytochrome P450 1A1 genetic polymorphisms to the development of head and neck cancers.
Reszka E; Czekaj P; Adamska J; Wasowicz W
Clin Chem Lab Med; 2008; 46(8):1090-6. PubMed ID: 18590468
[TBL] [Abstract][Full Text] [Related]
28. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Cancer Causes Control; 2005 Jun; 16(5):579-85. PubMed ID: 15986113
[TBL] [Abstract][Full Text] [Related]
29. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.
Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Vainio H; Uusitupa M; Hirvonen A
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):229-36. PubMed ID: 11303592
[TBL] [Abstract][Full Text] [Related]
30. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.
Jin JQ; Hu YY; Niu YM; Yang GL; Wu YY; Leng WD; Xia LY
World J Gastroenterol; 2011 Jan; 17(2):260-6. PubMed ID: 21246002
[TBL] [Abstract][Full Text] [Related]
31. CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population.
Srivastava A; Choudhuri G; Mittal B
Metabolism; 2010 Jun; 59(6):767-73. PubMed ID: 20005541
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma.
Liu G; Ghadirian P; Vesprini D; Hamel N; Paradis AJ; Lal G; Gallinger S; Narod SA; Foulkes WD
Br J Cancer; 2000 May; 82(10):1646-9. PubMed ID: 10817498
[TBL] [Abstract][Full Text] [Related]
33. Complement receptor 1 (A3650G RsaI and intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population.
Srivastava A; Mittal B
Scand J Immunol; 2009 Dec; 70(6):614-20. PubMed ID: 19906204
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.
Gsur A; Haidinger G; Hollaus P; Herbacek I; Madersbacher S; Trieb K; Pridun N; Mohn-Staudner A; Vetter N; Vutuc C; Micksche M
Anticancer Res; 2001; 21(3C):2237-42. PubMed ID: 11501853
[TBL] [Abstract][Full Text] [Related]
35. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women.
Yang XR; Wacholder S; Xu Z; Dean M; Clark V; Gold B; Brown LM; Stone BJ; Fraumeni JF; Caporaso NE
Cancer Lett; 2004 Oct; 214(2):197-204. PubMed ID: 15363546
[TBL] [Abstract][Full Text] [Related]
36. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
37. Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and clinical outcome in advanced nonsmall cell lung cancer patients.
Karacaoğlan V; Ada AO; Bilgen S; Çetinkaya GT; Soydaş E; Kunak CS; Alpar SM; Gülhan M; Işcan M
Turk J Med Sci; 2017 Apr; 47(2):554-562. PubMed ID: 28425245
[TBL] [Abstract][Full Text] [Related]
38. Evidence that genetic variants of metabolic detoxication and cell cycle control are not related to gallbladder cancer risk in Chilean women.
Tsuchiya Y; Baez S; Calvo A; Pruyas M; Nakamura K; Kiyohara C; Oyama M; Ikegami K; Yamamoto M
Int J Biol Markers; 2010; 25(2):75-8. PubMed ID: 20544687
[TBL] [Abstract][Full Text] [Related]
39. CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study.
San Jose C; Cabanillas A; Benitez J; Carrillo JA; Jimenez M; Gervasini G
BMC Cancer; 2010 Aug; 10():463. PubMed ID: 20804547
[TBL] [Abstract][Full Text] [Related]
40. [CYP1A1 polymorphisms, lack of glutathione S-transferase M1 (GSTM1), cooking oil fumes and lung cancer risk in non-smoking women].
Zhu XX; Hu CP; Gu QH
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Nov; 33(11):817-22. PubMed ID: 21211368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
